GNPX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
4.5M
-0.2%
4.5M
+27.7%
3.5M
+5.2%
3.3M
-28.5%
4.7M
R&D
2.7M
-2.3%
2.7M
+25.0%
2.2M
+0.2%
2.2M
-12.3%
2.5M
SG&A
1.8M
+3.0%
1.7M
+32.2%
1.3M
+14.7%
1.2M
-47.2%
2.2M
Operating Income
-4483984
+0.2%
-4494184
-27.7%
-3518632
-5.2%
-3345913
+28.5%
-4681784
EBITDA
-4483984
+0.2%
-4494184
-27.7%
-3518632
-5.2%
-3345913
+28.5%
-4681784
Net Income
-4447219
+0.3%
-4461895
-17.7%
-3790211
+0.2%
-3799240
+18.7%
-4674901
EPS (Basic)
$-9.40
+33.2%
$-14.08
+55.4%
$-31.59
+71.3%
$-110.00
+40.6%
$-185.30
EPS (Diluted)
$-9.40
+33.2%
$-14.08
+55.4%
$-31.59
+71.3%
$-110.00
+40.6%
$-185.30
Shares (Diluted)
473.2K
+49.7%
316.0K
+163.3%
120.0K
+247.1%
34.6K
+37.0%
25.2K
Genprex (GNPX) โ€” Financials